Log In
Print this Print this

Pollinex Quattro Ragweed

  Manage Alerts
Collapse Summary General Information
Company Allergy Therapeutics plc
DescriptionSubcutaneous ragweed allergy vaccine formulated with allergoids, tyrosine and the toll-like receptor 4 (TLR4) agonist monophosphoryl lipid A (MPL)
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationAllergy
Indication DetailsTreat ragweed allergy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today